Loading…

Cutting Edge: Link Between Innate and Adaptive Immunity: Toll-Like Receptor 2 Internalizes Antigen for Presentation to CD4+ T Cells and Could Be an Efficient Vaccine Target

An ideal vaccine for induction of CD4(+) T cell responses should induce local inflammation, maturation of APC, and peptide loading of MHC class II molecules. Ligation of Toll-like receptor (TLR) 2 provides the first two of these three criteria. We have studied whether targeting of TLR2 results in lo...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of immunology (1950) 2003-07, Vol.171 (1), p.32-36
Main Authors: Schjetne, Karoline W, Thompson, Keith M, Nilsen, Nadra, Flo, Trude H, Fleckenstein, Burkhard, Iversen, Jens-Gustav, Espevik, Terje, Bogen, Bjarne
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c370t-a1a5a255a1ff79ec73b4ca14eaced0c43d35345608e7dce992603d9bc601285b3
cites cdi_FETCH-LOGICAL-c370t-a1a5a255a1ff79ec73b4ca14eaced0c43d35345608e7dce992603d9bc601285b3
container_end_page 36
container_issue 1
container_start_page 32
container_title The Journal of immunology (1950)
container_volume 171
creator Schjetne, Karoline W
Thompson, Keith M
Nilsen, Nadra
Flo, Trude H
Fleckenstein, Burkhard
Iversen, Jens-Gustav
Espevik, Terje
Bogen, Bjarne
description An ideal vaccine for induction of CD4(+) T cell responses should induce local inflammation, maturation of APC, and peptide loading of MHC class II molecules. Ligation of Toll-like receptor (TLR) 2 provides the first two of these three criteria. We have studied whether targeting of TLR2 results in loading of MHC class II molecules and enhancement of CD4(+) T cell responses. To dissociate MHC class II presentation from APC maturation, we have used an antagonistic, mouse anti-human TLR2 mAb (TL2.1) as ligand and measured proliferation of a mouse Ckappa-specific human CD4(+) T cell clone. TL2.1 mAb was 100-1000 times more efficiently presented by APC compared with isotype-matched control mAb. Moreover, TL2.1 mAb was internalized into endosomes and processed by the conventional MHC class II pathway. This novel function of TLR2 represents a link between innate and adaptive immunity and indicates that TLR2 could be a promising target for vaccines.
doi_str_mv 10.4049/jimmunol.171.1.32
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73350373</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73350373</sourcerecordid><originalsourceid>FETCH-LOGICAL-c370t-a1a5a255a1ff79ec73b4ca14eaced0c43d35345608e7dce992603d9bc601285b3</originalsourceid><addsrcrecordid>eNpFkVFv0zAUhS0EYl3hB_CC_AIvKJ0dJ06ztxK6UakSCBVeLde-ybw5TrEdou038SPxaGEvvrL8nXOsexB6Q8miIEV9cWv6fnSDXdCKLuiC5c_QjJYlyTgn_DmaEZLnGa14dYbOQ7glhHCSFy_RGc2XlNdLMkO_mzFG4zq81h1c4q1xd_gjxAnA4Y1zMgKWTuOVlodofgHePCaaeH-Jd4O12dbcAf4GCg5x8DhPkgjeSWseIOCVi6ZLPm16-uohgIsymsHhOODmU_EB73AD1oa_Cc0wWp2i0wWv29Yok3D8QyplHOCd9B3EV-hFK22A16c5R9-v1rvmc7b9cr1pVttMsYrETFJZyrwsJW3bqgZVsX2hJC1AKtBEFUyzkhUlJ0uotIK6zjlhut4rTtJiyj2bo_dH34Mffo4QouhNUOmr0sEwBlExVhKWzjmiR1D5IQQPrTh400t_LygRjxWJfxWJVJGgguVJ8_ZkPu570E-KUycJeHcEbkx3MxkPIvTS2oRTMU3Tf6M__NydAA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73350373</pqid></control><display><type>article</type><title>Cutting Edge: Link Between Innate and Adaptive Immunity: Toll-Like Receptor 2 Internalizes Antigen for Presentation to CD4+ T Cells and Could Be an Efficient Vaccine Target</title><source>EZB Electronic Journals Library</source><creator>Schjetne, Karoline W ; Thompson, Keith M ; Nilsen, Nadra ; Flo, Trude H ; Fleckenstein, Burkhard ; Iversen, Jens-Gustav ; Espevik, Terje ; Bogen, Bjarne</creator><creatorcontrib>Schjetne, Karoline W ; Thompson, Keith M ; Nilsen, Nadra ; Flo, Trude H ; Fleckenstein, Burkhard ; Iversen, Jens-Gustav ; Espevik, Terje ; Bogen, Bjarne</creatorcontrib><description>An ideal vaccine for induction of CD4(+) T cell responses should induce local inflammation, maturation of APC, and peptide loading of MHC class II molecules. Ligation of Toll-like receptor (TLR) 2 provides the first two of these three criteria. We have studied whether targeting of TLR2 results in loading of MHC class II molecules and enhancement of CD4(+) T cell responses. To dissociate MHC class II presentation from APC maturation, we have used an antagonistic, mouse anti-human TLR2 mAb (TL2.1) as ligand and measured proliferation of a mouse Ckappa-specific human CD4(+) T cell clone. TL2.1 mAb was 100-1000 times more efficiently presented by APC compared with isotype-matched control mAb. Moreover, TL2.1 mAb was internalized into endosomes and processed by the conventional MHC class II pathway. This novel function of TLR2 represents a link between innate and adaptive immunity and indicates that TLR2 could be a promising target for vaccines.</description><identifier>ISSN: 0022-1767</identifier><identifier>EISSN: 1550-6606</identifier><identifier>DOI: 10.4049/jimmunol.171.1.32</identifier><identifier>PMID: 12816980</identifier><language>eng</language><publisher>United States: Am Assoc Immnol</publisher><subject>Amino Acid Sequence ; Antibodies, Monoclonal - metabolism ; Antibodies, Monoclonal - pharmacology ; Antibody Specificity ; Antigen Presentation - genetics ; Antigen-Presenting Cells - cytology ; Antigen-Presenting Cells - immunology ; Antigen-Presenting Cells - metabolism ; Antigens - genetics ; Antigens - metabolism ; Bacterial Vaccines - immunology ; CD4-Positive T-Lymphocytes - immunology ; CD4-Positive T-Lymphocytes - metabolism ; Cell Line ; Clone Cells ; Endocytosis - genetics ; Endocytosis - immunology ; Endosomes - immunology ; Endosomes - metabolism ; Epitopes, T-Lymphocyte - metabolism ; Humans ; Immunity, Active ; Immunity, Innate ; Immunoglobulin Constant Regions - metabolism ; Immunoglobulin kappa-Chains - metabolism ; Ligands ; Membrane Glycoproteins - genetics ; Membrane Glycoproteins - immunology ; Membrane Glycoproteins - metabolism ; Molecular Sequence Data ; Receptors, Cell Surface - genetics ; Receptors, Cell Surface - immunology ; Receptors, Cell Surface - metabolism ; Toll-Like Receptor 2 ; Toll-Like Receptors</subject><ispartof>The Journal of immunology (1950), 2003-07, Vol.171 (1), p.32-36</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c370t-a1a5a255a1ff79ec73b4ca14eaced0c43d35345608e7dce992603d9bc601285b3</citedby><cites>FETCH-LOGICAL-c370t-a1a5a255a1ff79ec73b4ca14eaced0c43d35345608e7dce992603d9bc601285b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12816980$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schjetne, Karoline W</creatorcontrib><creatorcontrib>Thompson, Keith M</creatorcontrib><creatorcontrib>Nilsen, Nadra</creatorcontrib><creatorcontrib>Flo, Trude H</creatorcontrib><creatorcontrib>Fleckenstein, Burkhard</creatorcontrib><creatorcontrib>Iversen, Jens-Gustav</creatorcontrib><creatorcontrib>Espevik, Terje</creatorcontrib><creatorcontrib>Bogen, Bjarne</creatorcontrib><title>Cutting Edge: Link Between Innate and Adaptive Immunity: Toll-Like Receptor 2 Internalizes Antigen for Presentation to CD4+ T Cells and Could Be an Efficient Vaccine Target</title><title>The Journal of immunology (1950)</title><addtitle>J Immunol</addtitle><description>An ideal vaccine for induction of CD4(+) T cell responses should induce local inflammation, maturation of APC, and peptide loading of MHC class II molecules. Ligation of Toll-like receptor (TLR) 2 provides the first two of these three criteria. We have studied whether targeting of TLR2 results in loading of MHC class II molecules and enhancement of CD4(+) T cell responses. To dissociate MHC class II presentation from APC maturation, we have used an antagonistic, mouse anti-human TLR2 mAb (TL2.1) as ligand and measured proliferation of a mouse Ckappa-specific human CD4(+) T cell clone. TL2.1 mAb was 100-1000 times more efficiently presented by APC compared with isotype-matched control mAb. Moreover, TL2.1 mAb was internalized into endosomes and processed by the conventional MHC class II pathway. This novel function of TLR2 represents a link between innate and adaptive immunity and indicates that TLR2 could be a promising target for vaccines.</description><subject>Amino Acid Sequence</subject><subject>Antibodies, Monoclonal - metabolism</subject><subject>Antibodies, Monoclonal - pharmacology</subject><subject>Antibody Specificity</subject><subject>Antigen Presentation - genetics</subject><subject>Antigen-Presenting Cells - cytology</subject><subject>Antigen-Presenting Cells - immunology</subject><subject>Antigen-Presenting Cells - metabolism</subject><subject>Antigens - genetics</subject><subject>Antigens - metabolism</subject><subject>Bacterial Vaccines - immunology</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>CD4-Positive T-Lymphocytes - metabolism</subject><subject>Cell Line</subject><subject>Clone Cells</subject><subject>Endocytosis - genetics</subject><subject>Endocytosis - immunology</subject><subject>Endosomes - immunology</subject><subject>Endosomes - metabolism</subject><subject>Epitopes, T-Lymphocyte - metabolism</subject><subject>Humans</subject><subject>Immunity, Active</subject><subject>Immunity, Innate</subject><subject>Immunoglobulin Constant Regions - metabolism</subject><subject>Immunoglobulin kappa-Chains - metabolism</subject><subject>Ligands</subject><subject>Membrane Glycoproteins - genetics</subject><subject>Membrane Glycoproteins - immunology</subject><subject>Membrane Glycoproteins - metabolism</subject><subject>Molecular Sequence Data</subject><subject>Receptors, Cell Surface - genetics</subject><subject>Receptors, Cell Surface - immunology</subject><subject>Receptors, Cell Surface - metabolism</subject><subject>Toll-Like Receptor 2</subject><subject>Toll-Like Receptors</subject><issn>0022-1767</issn><issn>1550-6606</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNpFkVFv0zAUhS0EYl3hB_CC_AIvKJ0dJ06ztxK6UakSCBVeLde-ybw5TrEdou038SPxaGEvvrL8nXOsexB6Q8miIEV9cWv6fnSDXdCKLuiC5c_QjJYlyTgn_DmaEZLnGa14dYbOQ7glhHCSFy_RGc2XlNdLMkO_mzFG4zq81h1c4q1xd_gjxAnA4Y1zMgKWTuOVlodofgHePCaaeH-Jd4O12dbcAf4GCg5x8DhPkgjeSWseIOCVi6ZLPm16-uohgIsymsHhOODmU_EB73AD1oa_Cc0wWp2i0wWv29Yok3D8QyplHOCd9B3EV-hFK22A16c5R9-v1rvmc7b9cr1pVttMsYrETFJZyrwsJW3bqgZVsX2hJC1AKtBEFUyzkhUlJ0uotIK6zjlhut4rTtJiyj2bo_dH34Mffo4QouhNUOmr0sEwBlExVhKWzjmiR1D5IQQPrTh400t_LygRjxWJfxWJVJGgguVJ8_ZkPu570E-KUycJeHcEbkx3MxkPIvTS2oRTMU3Tf6M__NydAA</recordid><startdate>20030701</startdate><enddate>20030701</enddate><creator>Schjetne, Karoline W</creator><creator>Thompson, Keith M</creator><creator>Nilsen, Nadra</creator><creator>Flo, Trude H</creator><creator>Fleckenstein, Burkhard</creator><creator>Iversen, Jens-Gustav</creator><creator>Espevik, Terje</creator><creator>Bogen, Bjarne</creator><general>Am Assoc Immnol</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20030701</creationdate><title>Cutting Edge: Link Between Innate and Adaptive Immunity: Toll-Like Receptor 2 Internalizes Antigen for Presentation to CD4+ T Cells and Could Be an Efficient Vaccine Target</title><author>Schjetne, Karoline W ; Thompson, Keith M ; Nilsen, Nadra ; Flo, Trude H ; Fleckenstein, Burkhard ; Iversen, Jens-Gustav ; Espevik, Terje ; Bogen, Bjarne</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c370t-a1a5a255a1ff79ec73b4ca14eaced0c43d35345608e7dce992603d9bc601285b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Amino Acid Sequence</topic><topic>Antibodies, Monoclonal - metabolism</topic><topic>Antibodies, Monoclonal - pharmacology</topic><topic>Antibody Specificity</topic><topic>Antigen Presentation - genetics</topic><topic>Antigen-Presenting Cells - cytology</topic><topic>Antigen-Presenting Cells - immunology</topic><topic>Antigen-Presenting Cells - metabolism</topic><topic>Antigens - genetics</topic><topic>Antigens - metabolism</topic><topic>Bacterial Vaccines - immunology</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>CD4-Positive T-Lymphocytes - metabolism</topic><topic>Cell Line</topic><topic>Clone Cells</topic><topic>Endocytosis - genetics</topic><topic>Endocytosis - immunology</topic><topic>Endosomes - immunology</topic><topic>Endosomes - metabolism</topic><topic>Epitopes, T-Lymphocyte - metabolism</topic><topic>Humans</topic><topic>Immunity, Active</topic><topic>Immunity, Innate</topic><topic>Immunoglobulin Constant Regions - metabolism</topic><topic>Immunoglobulin kappa-Chains - metabolism</topic><topic>Ligands</topic><topic>Membrane Glycoproteins - genetics</topic><topic>Membrane Glycoproteins - immunology</topic><topic>Membrane Glycoproteins - metabolism</topic><topic>Molecular Sequence Data</topic><topic>Receptors, Cell Surface - genetics</topic><topic>Receptors, Cell Surface - immunology</topic><topic>Receptors, Cell Surface - metabolism</topic><topic>Toll-Like Receptor 2</topic><topic>Toll-Like Receptors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schjetne, Karoline W</creatorcontrib><creatorcontrib>Thompson, Keith M</creatorcontrib><creatorcontrib>Nilsen, Nadra</creatorcontrib><creatorcontrib>Flo, Trude H</creatorcontrib><creatorcontrib>Fleckenstein, Burkhard</creatorcontrib><creatorcontrib>Iversen, Jens-Gustav</creatorcontrib><creatorcontrib>Espevik, Terje</creatorcontrib><creatorcontrib>Bogen, Bjarne</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of immunology (1950)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schjetne, Karoline W</au><au>Thompson, Keith M</au><au>Nilsen, Nadra</au><au>Flo, Trude H</au><au>Fleckenstein, Burkhard</au><au>Iversen, Jens-Gustav</au><au>Espevik, Terje</au><au>Bogen, Bjarne</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cutting Edge: Link Between Innate and Adaptive Immunity: Toll-Like Receptor 2 Internalizes Antigen for Presentation to CD4+ T Cells and Could Be an Efficient Vaccine Target</atitle><jtitle>The Journal of immunology (1950)</jtitle><addtitle>J Immunol</addtitle><date>2003-07-01</date><risdate>2003</risdate><volume>171</volume><issue>1</issue><spage>32</spage><epage>36</epage><pages>32-36</pages><issn>0022-1767</issn><eissn>1550-6606</eissn><abstract>An ideal vaccine for induction of CD4(+) T cell responses should induce local inflammation, maturation of APC, and peptide loading of MHC class II molecules. Ligation of Toll-like receptor (TLR) 2 provides the first two of these three criteria. We have studied whether targeting of TLR2 results in loading of MHC class II molecules and enhancement of CD4(+) T cell responses. To dissociate MHC class II presentation from APC maturation, we have used an antagonistic, mouse anti-human TLR2 mAb (TL2.1) as ligand and measured proliferation of a mouse Ckappa-specific human CD4(+) T cell clone. TL2.1 mAb was 100-1000 times more efficiently presented by APC compared with isotype-matched control mAb. Moreover, TL2.1 mAb was internalized into endosomes and processed by the conventional MHC class II pathway. This novel function of TLR2 represents a link between innate and adaptive immunity and indicates that TLR2 could be a promising target for vaccines.</abstract><cop>United States</cop><pub>Am Assoc Immnol</pub><pmid>12816980</pmid><doi>10.4049/jimmunol.171.1.32</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1767
ispartof The Journal of immunology (1950), 2003-07, Vol.171 (1), p.32-36
issn 0022-1767
1550-6606
language eng
recordid cdi_proquest_miscellaneous_73350373
source EZB Electronic Journals Library
subjects Amino Acid Sequence
Antibodies, Monoclonal - metabolism
Antibodies, Monoclonal - pharmacology
Antibody Specificity
Antigen Presentation - genetics
Antigen-Presenting Cells - cytology
Antigen-Presenting Cells - immunology
Antigen-Presenting Cells - metabolism
Antigens - genetics
Antigens - metabolism
Bacterial Vaccines - immunology
CD4-Positive T-Lymphocytes - immunology
CD4-Positive T-Lymphocytes - metabolism
Cell Line
Clone Cells
Endocytosis - genetics
Endocytosis - immunology
Endosomes - immunology
Endosomes - metabolism
Epitopes, T-Lymphocyte - metabolism
Humans
Immunity, Active
Immunity, Innate
Immunoglobulin Constant Regions - metabolism
Immunoglobulin kappa-Chains - metabolism
Ligands
Membrane Glycoproteins - genetics
Membrane Glycoproteins - immunology
Membrane Glycoproteins - metabolism
Molecular Sequence Data
Receptors, Cell Surface - genetics
Receptors, Cell Surface - immunology
Receptors, Cell Surface - metabolism
Toll-Like Receptor 2
Toll-Like Receptors
title Cutting Edge: Link Between Innate and Adaptive Immunity: Toll-Like Receptor 2 Internalizes Antigen for Presentation to CD4+ T Cells and Could Be an Efficient Vaccine Target
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T22%3A14%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cutting%20Edge:%20Link%20Between%20Innate%20and%20Adaptive%20Immunity:%20Toll-Like%20Receptor%202%20Internalizes%20Antigen%20for%20Presentation%20to%20CD4+%20T%20Cells%20and%20Could%20Be%20an%20Efficient%20Vaccine%20Target&rft.jtitle=The%20Journal%20of%20immunology%20(1950)&rft.au=Schjetne,%20Karoline%20W&rft.date=2003-07-01&rft.volume=171&rft.issue=1&rft.spage=32&rft.epage=36&rft.pages=32-36&rft.issn=0022-1767&rft.eissn=1550-6606&rft_id=info:doi/10.4049/jimmunol.171.1.32&rft_dat=%3Cproquest_cross%3E73350373%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c370t-a1a5a255a1ff79ec73b4ca14eaced0c43d35345608e7dce992603d9bc601285b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=73350373&rft_id=info:pmid/12816980&rfr_iscdi=true